The Real Anthony Fauci: Bill Gates, Big Pharma, and the Global War on Democracy and Public Health

by Robert F. Kennedy Jr.

However, six months into the Ebola study, the trial’s Safety Review Board suddenly pulled both remdesivir and ZMapp from the trial.12 Remdesivir, it turned out, was hideously dangerous. Within 28 days, subjects taking remdesivir had lethal side effects including multiple organ failure, acute kidney failure, septic shock, and hypotension, and 54 percent of the remdesivir group died—the highest mortality rate among the four experimental drugs.13 Anthony Fauci’s drug, ZMapp, ran up the second-highest body count at 44 percent. NIAID was the primary funder of this study, and its researchers published the bad news about remdesivir in the New England Journal of Medicine in December 2019.14 By then, COVID-19 was already circulating in Wuhan. But two months later, on February 25, 2020, Dr. Fauci announced, with great fanfare, that he was enrolling hospitalized COVID patients in a clinical trial to study remdesivir’s efficacy.15 For important context, this was a month before the WHO declared the new pandemic, a time that there were only fourteen confirmed COVID cases in the United States, most from the Diamond Princess cruise ship. These individuals were among the first wave of COVID-19 hospitalizations from whom NIAID recruited the 400 US volunteers for Dr. Fauci’s remdesivir trial.16 Dr. Fauci’s press release said only that remdesivir “has shown promise in animal models for treating Middle East Respiratory Syndrome (MERS).”17 It’s unclear, then, if NIAID informed these frightened ...